» Articles » PMID: 15231742

Transcript Level Alterations Reflect Gene Dosage Effects Across Multiple Tissues in a Mouse Model of Down Syndrome

Overview
Journal Genome Res
Specialty Genetics
Date 2004 Jul 3
PMID 15231742
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

Human trisomy 21, which results in Down syndrome (DS), is one of the most complicated congenital genetic anomalies compatible with life, yet little is known about the molecular basis of DS. It is generally accepted that chromosome 21 (Chr21) transcripts are overexpressed by about 50% in cells with an extra copy of this chromosome. However, this assumption is difficult to test in humans due to limited access to tissues, and direct support for this idea is available for only a few Chr21 genes or in a limited number of tissues. The Ts65Dn mouse is widely used as a model for studies of DS because it is at dosage imbalance for the orthologs of about half of the 284 Chr21 genes. Ts65Dn mice have several features that directly parallel developmental anomalies of DS. Here we compared the expression of 136 mouse orthologs of Chr21 genes in nine tissues of the trisomic and euploid mice. Nearly all of the 77 genes which are at dosage imbalance in Ts65Dn showed increased transcript levels in the tested tissues, providing direct support for a simple model of increased transcription proportional to the gene copy number. However, several genes escaped this rule, suggesting that they may be controlled by additional tissue-specific regulatory mechanisms revealed in the trisomic situation.

Citing Articles

Patterns of Aneuploidy and Signaling Consequences in Cancer.

Zhakula-Kostadinova N, Taylor A Cancer Res. 2024; 84(16):2575-2587.

PMID: 38924459 PMC: 11325152. DOI: 10.1158/0008-5472.CAN-24-0169.


Aberrant CD8T cells drive reproductive dysfunction in female mice with elevated IFN-γ levels.

Bafor E, Erwin-Cohen R, Martin T, Baker C, Kimmel A, Duverger O Front Immunol. 2024; 15:1368572.

PMID: 38698852 PMC: 11064017. DOI: 10.3389/fimmu.2024.1368572.


Sex-specific developmental alterations in DYRK1A expression in the brain of a Down syndrome mouse model.

Hawley L, Stringer M, Deal A, Folz A, Goodlett C, Roper R Neurobiol Dis. 2023; 190:106359.

PMID: 37992782 PMC: 10843801. DOI: 10.1016/j.nbd.2023.106359.


Gene dosage compensation: Origins, criteria to identify compensated genes, and mechanisms including sensor loops as an emerging systems-level property in cancer.

Bravo-Estupinan D, Aguilar-Guerrero K, Quiros S, Acon M, Marin-Muller C, Ibanez-Hernandez M Cancer Med. 2023; 12(24):22130-22155.

PMID: 37987212 PMC: 10757140. DOI: 10.1002/cam4.6719.


Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.

Gautier M, Kelley C, Lee S, Alldred M, McDaid J, Mufson E Neurobiol Dis. 2023; 188:106332.

PMID: 37890559 PMC: 10752300. DOI: 10.1016/j.nbd.2023.106332.


References
1.
Egeo A, Di Lisi1 R, Sandri C, Mazzocco M, Lapide M, Schiaffino S . Developmental expression of the SH3BGR gene, mapping to the Down syndrome heart critical region. Mech Dev. 2000; 90(2):313-6. DOI: 10.1016/s0925-4773(99)00253-1. View

2.
Mao R, Zielke C, Zielke H, Pevsner J . Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics. 2003; 81(5):457-67. DOI: 10.1016/s0888-7543(03)00035-1. View

3.
Lietard J, Theret N, Rehn M, Musso O, Dargere D, Pihlajaniemi T . The promoter of the long variant of collagen XVIII, the precursor of endostatin, contains liver-specific regulatory elements. Hepatology. 2000; 32(6):1377-85. DOI: 10.1053/jhep.2000.20066. View

4.
Chrast R, Scott H, Papasavvas M, Rossier C, Antonarakis E, Barras C . The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals. Genome Res. 2000; 10(12):2006-21. PMC: 313062. DOI: 10.1101/gr.10.12.2006. View

5.
Reeves R, Baxter L, Richtsmeier J . Too much of a good thing: mechanisms of gene action in Down syndrome. Trends Genet. 2001; 17(2):83-8. DOI: 10.1016/s0168-9525(00)02172-7. View